ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT

Autor:	C. d’Hautefeuille, S. Abbou, L. El-Gourari-Miaz, A. Lambilliotte, C. Renard, J. Landman-Parker, S. Gourdon, L. Metayer, T. Leblanc, H. Pacquement, F. Rabian, A. Verschuur, J. Brasme, F. Millot, A. Pagnier, N. Buchbinder, P. Rorhlich, V. Minard-Colin, L. Brugières, S. Ducassou, C. Rigaud
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Leukemia Research. 121:S68-S69
ISSN:	0145-2126
DOI:	10.1016/s0145-2126(22)00308-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4f48a734e6e3825e3a1404280a64a07 https://doi.org/10.1016/s0145-2126(22)00308-3 Zobrazit plný text záznamu Full Text from ScienceDirect